Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 1,487,557 shares of the real estate investment trust's stock, valued at approximately $30,153,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.21% of Healthpeak Properties at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently bought and sold shares of DOC. Mizuho Bank Ltd. acquired a new stake in Healthpeak Properties in the 4th quarter worth $28,000. Harvest Fund Management Co. Ltd acquired a new stake in Healthpeak Properties in the 4th quarter worth $30,000. Covestor Ltd grew its position in Healthpeak Properties by 173.8% in the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock worth $37,000 after purchasing an additional 1,152 shares during the last quarter. Kestra Investment Management LLC acquired a new stake in Healthpeak Properties in the 4th quarter worth $45,000. Finally, Kapitalo Investimentos Ltda acquired a new stake in Healthpeak Properties in the 4th quarter worth $46,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Healthpeak Properties
In related news, Director John T. Thomas bought 4,200 shares of Healthpeak Properties stock in a transaction dated Monday, April 28th. The shares were bought at an average cost of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the transaction, the director now owns 813,566 shares of the company's stock, valued at approximately $14,514,017.44. This trade represents a 0.52% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Tommy G. Thompson bought 5,777 shares of Healthpeak Properties stock in a transaction dated Wednesday, May 28th. The shares were bought at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the completion of the transaction, the director now directly owns 144,290 shares of the company's stock, valued at $2,491,888.30. This represents a 4.17% increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 29,764 shares of company stock worth $521,909 over the last ninety days. Corporate insiders own 0.23% of the company's stock.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on DOC. Wall Street Zen lowered shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Thursday, May 1st. Evercore ISI lowered their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Robert W. Baird lowered their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 29th. Argus reissued a "buy" rating and issued a $25.00 target price on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Finally, Wedbush lowered their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $23.45.
Check Out Our Latest Report on Healthpeak Properties
Healthpeak Properties Price Performance
NYSE:DOC traded down $0.11 on Friday, reaching $17.41. The stock had a trading volume of 9,932,437 shares, compared to its average volume of 5,144,324. The company has a market capitalization of $12.10 billion, a P/E ratio of 49.74, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05. Healthpeak Properties, Inc. has a 1-year low of $16.64 and a 1-year high of $23.26. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The stock has a fifty day moving average price of $18.16 and a 200-day moving average price of $19.72.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting analysts' consensus estimates of $0.46. The firm had revenue of $702.89 million for the quarter, compared to analyst estimates of $690.76 million. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The company's revenue for the quarter was up 15.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.45 earnings per share. Research analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.
Healthpeak Properties Dividend Announcement
The company also recently declared a dividend, which was paid on Friday, May 30th. Shareholders of record on Tuesday, May 20th were given a $0.1017 dividend. The ex-dividend date was Monday, May 19th. This represents a yield of 7.05%. Healthpeak Properties's dividend payout ratio (DPR) is presently 305.00%.
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Recommended Stories

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.